• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: EDWARDS LIFESCIENCES EDWARDS SAPIEN 3 ULTRA TRANSCATHETER HEART VALVE SYSTEM; AORTIC VALVE, PROSTHESIS, PERCUTANEOUSLY DELIVERED

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

EDWARDS LIFESCIENCES EDWARDS SAPIEN 3 ULTRA TRANSCATHETER HEART VALVE SYSTEM; AORTIC VALVE, PROSTHESIS, PERCUTANEOUSLY DELIVERED Back to Search Results
Model Number 9750TFX26A
Device Problem Device Damaged by Another Device (2915)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 12/21/2022
Event Type  malfunction  
Manufacturer Narrative
Investigation is ongoing device not returned.
 
Event Description
As reported, upon insertion of the delivery system into the 14fr e-sheath, the sheath kinked at the skin and the valve strut came through the side wall of the sheath outside of the body, one of the valve struts was partially bent due to the valve hitting the kink in the sheath.They retrieved the valve, sheath and delivery system from the patient and a 16fr e-sheath was requested and inserted.They prepared a new valve and delivery system and the procedure went on as normal without any complications or harm to the patient.
 
Manufacturer Narrative
H2, h6 updated.Component code 527 is no longer applicable the valve was not returned; therefore, a visual inspection, functional testing, or dimensional testing was not performed.Imagery was provided by the site and revealed the following: patients vasculature had presence of tortuosity.A device history record (dhr) review was done and did not reveal any manufacturing nonconformance issues that would have contributed to the event.The complaint for failure frame damage was unable to be confirmed, therefore a lot history review and complaint history review is not required.The following instructions for use (ifu) and manual were reviewed: commander delivery system with s3/s3u/s3ur ifu, us, s3u, commander, esheath+ device preparation, s3u, commander, esheath+ procedural manual.No ifu or training deficiencies were identified.No device was returned and there is no evidence to support a manufacturing/design defect potentially contributed to the complaint, therefore a manufacturing mitigation review is not required.A risk assessment was performed on the reported event and revealed no evidence of product non conformances or labeling/ifu inadequacies.The complaint for failure frame damage was unable to be confirmed due to unavailability of returned device/relevant imagery/medical records.A review of the dhr and lot history did not provide any indication that a manufacturing nonconformance contributed to the complaint event.A review of ifu/training materials revealed no deficiencies.As reported, upon insertion of the delivery system into 14fr esheath, the sheath kinked at the skin and the valve strut came through the side wall of the sheath outside of the body.One of the valve struts was partially bent due to the valve hitting the kink in the sheath.The strut punctured through the sidewall of the sheath.Per training manual, push force can vary due to angle of access and insertion, thv size, vessel diameter, tortuosity and degree of calcification, and do not overmanipulate the sheath at any time.In this case, it is likely that the kinked sheath created a restricted pathway during delivery system advancement, and further excessive device manipulation leads to valve struts interacting with the sheath shaft, resulting in valve bent strut.As such, available information suggests that procedural factors (excessive device manipulation, sheath kinked) may have contributed to the complaint event.However, a definitive root cause was unable to be determined.Since no manufacturing nonconformances or labeling and ifu and training deficiencies were identified, no product nonconformance was confirmed, and the complaint occurrence rate did not exceed the applicable trending control limit, no corrective and preventative actions (capa) nor product risk assessment (pra) escalation are required.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
EDWARDS SAPIEN 3 ULTRA TRANSCATHETER HEART VALVE SYSTEM
Type of Device
AORTIC VALVE, PROSTHESIS, PERCUTANEOUSLY DELIVERED
Manufacturer (Section D)
EDWARDS LIFESCIENCES
1 edwards way
irvine CA 92614
Manufacturer (Section G)
EDWARDS LIFESCIENCES
1 edwards way
irvine CA 92614
Manufacturer Contact
renee van dorne
1 edwards way
irvine, CA 92614
9492506385
MDR Report Key16156127
MDR Text Key307298955
Report Number2015691-2023-10145
Device Sequence Number1
Product Code NPT
UDI-Device Identifier00690103201338
UDI-Public(01)00690103201338(17)250719
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P140031
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional,User Facility
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 03/06/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model Number9750TFX26A
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Initial Date Manufacturer Received 12/21/2022
Initial Date FDA Received01/13/2023
Supplement Dates Manufacturer Received02/27/2023
Supplement Dates FDA Received03/06/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured07/20/2022
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient SexMale
-
-